Chronic daily headaches can be a difficult problem in children as well as adults. Over half of the cases of chronic daily headaches in adults are thought to be due to medication-overuse headache ...

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine days.

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

The Headache Medicine Fellowship is a one-year UCNS-accredited fellowship program with an optional second year focusing on research. Our fellowship offers a comprehensive training experience designed ...

26, 2025 — For children and teens living ... Reduce Ischemic Stroke Risk in Women With Migraines Jan. 30, 2025 — Propranolol, a beta blocker medication used for treating high blood pressure ...

To tackle childhood pain holistically, architecture is part of the treatment plan at UCSF's pain-focused Stad Center.

DR GUMI, the first FDA-approved acetaminophen gummy pain and fever reducer medicine for children, officially launches in Southern California, offering parents a stress-free alternative to traditional ...

Ethan Brautigam, 13, had a sudden intense headache caused ... pediatric neurosurgeon at Texas Children's Hospital and assistant professor at Baylor College of Medicine. About one in 100,000 ...

Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.